Skip Nav Destination
1-10 of 10
Keywords: Diffuse large B cell lymphomaClose
Acta Haematol (2019) 142 (2): 64–70.
Published Online: 16 May 2019
...Hui Du; Lei Gao; Jing Luan; Hangfan Zhang; Taiwu Xiao Diffuse large B cell lymphoma (DLBCL), an aggressive cancer of the B cells, is the most common subtype of non-Hodgkin lymphoma (NHL) worldwide. In China, the cases of DLBCL increase yearly. C-X-C chemokine receptor 4 (CXCR4) has been implicated...
Acta Haematol (2017) 137 (2): 76–85.
Published Online: 12 January 2017
... investigated the usefulness of the ALI to predict chemotherapy response and survival in 212 patients with diffuse large B cell lymphoma (DLBCL) treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemotherapy. Methods: Patients were allocated to a low ALI group ( n...
Wenshuang Ding, Sha Zhao, Jianchao Wang, Qunpei Yang, Hong Sun, Jiaqi Yan, Limin Gao, Wenqing Yao, Wenyan Zhang, Weiping Liu
Acta Haematol (2015) 135 (1): 21–28.
Published Online: 08 December 2015
... and the median age was 55 years. The percent of patients with lymphoma involvement in the stomach was 52% (n = 522), and the remaining 48% (n = 484) had intestinal tract involvement. Histologically, diffuse large B cell lymphoma (DLBCL) was the most common subtype in all of the GIT lymphoma cases, and was also...
Acta Haematol (2015) 133 (2): 179–182.
Published Online: 11 October 2014
...Kwai Han Yoo; Ji Yun Lee; Sung Hee Lim; Young Hyeh Ko; Seok Jin Kim; Won Seog Kim Background: The simultaneous presentation of systemic diffuse large B cell lymphoma (DLBCL) with central nervous system (CNS) disease is not well controlled by either R-CHOP or systemic methotrexate (MTX) alone...
Junshik Hong, Hyun-Hwa Yoon, Hee Kyung Ahn, Sun Jin Sym, Jinny Park, Pil-Whan Park, Jeong Yeal Ahn, Sanghui Park, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
Acta Haematol (2013) 130 (4): 305–311.
Published Online: 31 August 2013
...; however, its role beyond initial diagnosis has not yet been defined. Methods: This study was conducted as a retrospective analysis of patients with diffuse large B cell lymphoma (DLBCL) treated with R-CHOP21, who had undergone regular checks for LDH during immunochemotherapy (n = 119) and during...
Acta Haematol (2011) 126 (3): 141–146.
Published Online: 07 July 2011
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Diffuse large B cell lymphoma Total hip arthroplasty Total knee arthroplasty Lymphoma is the seventh most common...
Yong Park, Yoon Ji Choi, Se Jong Park, Se Ryeon Lee, Hwa Jung Sung, Kyong Hwa Park, Soek Jin Kim, Chul Won Choi, Kwang Yoon Jung, Byung Soo Kim
Acta Haematol (2011) 126 (2): 79–86.
Published Online: 04 May 2011
.... We evaluated the prognostic significance of the pretreatment serum level of 15-kDa granulysin in patients with diffuse large B cell lymphoma (DLBCL). Patients and Methods: A retrospective analysis was conducted on 88 DLBCL patients treated homogeneously with standard chemotherapy. The granulysin...
Shuhua Yi, Gang An, Junyuan Qi, Dehui Zou, Yaozhong Zhao, Peihong Zhang, Huishu Chen, Jun Wang, Lugui Qiu
Acta Haematol (2010) 124 (4): 239–244.
Published Online: 07 December 2010
...Shuhua Yi; Gang An; Junyuan Qi; Dehui Zou; Yaozhong Zhao; Peihong Zhang; Huishu Chen; Jun Wang; Lugui Qiu Background: Peripheral T cell lymphomas (PTCL) have been demonstrated to have a poorer prognosis than diffuse large B cell lymphoma (DLBCL) due to a high frequency of bone marrow involvement...
Naoto Tomita, Kengo Takeuchi, Rie Hyo, Chizuko Hashimoto, Sachiya Takemura, Jun Taguchi, Hiroyuki Fujita, Shin Fujisawa, Koji Ogawa, Shigeki Motomura, Yoshiaki Ishigatsubo
Acta Haematol (2009) 121 (4): 196–201.
Published Online: 26 May 2009
...-deficient B cell malignancies are often observed, their details are barely known. Methods: We retrospectively analyzed LCR-negative diffuse large B cell lymphoma (DLBCL) to elucidate their clinical features. Consecutive DLBCL patients (n = 119), whose histological diagnostic specimens were analyzed by flow...
Acta Haematol (2005) 114 (4): 255–259.
Published Online: 02 November 2005
.... Milpied et al. [ 11 ] reported that HDT was superior to CHOP in terms of event-free survival rate (p = 0.037) but it is important to remember that the CHOP regimen is no longer the gold standard for the treatment of diffuse large B cell lymphoma (DLBCL). In fact, the combination of anti-CD20 (rituximab...